¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"T46"¿¡ ´ëÇÑ Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú :
5
ÆäÀÌÁö:
1
ÄÚµå
¿µ¹®
ÇѱÛ
T46.4
Angiotensin-converting-enzyme inhibitors
¾ÈÁö¿ÀÅٽŠÀüȯȿ¼Ò ¾ïÁ¦Á¦
T46.6
Antihyperlipidaemic and antiarteriosclerotic drugs
Ç×°íÁöÁúÇ÷Áõ ¹× Ç×µ¿¸Æ°æÈÁõ ¾à¹°
T46.8
Antivaricose drugs, including sclerosing agents
°æÈ¼º ¾à¹° Æ÷ÇÔÇÑ Ç×Á¤¸Æ·ù¼º ¾à¹°
T46.1
Calcium-channel blockers
Ä®½· Åë·Î ºÀ¼âÁ¦
T46.0
Cardiac-stimulant glycosides and drugs of similar action
½ÉÀåÈïºÐÁ¦ ¹è´çü ¹× À¯»çÀÛ¿ëÀÇ ¾à¹°
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
ÄÚµå
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½